The UK is not the only market where the politics of healthcare can be highly febrile. In the US, where there is a presidential election this year, Donald Trump has been desperate to undo health insurance reforms introduced by Barack Obama, his predecessor. Debate in America has also been intense about the high price of prescription drugs and whether the government should intervene to bring down costs for patients.
Against this backdrop sits Worldwide Healthcare Trust, one of an array of ways that investors can take exposure to healthcare and drugs and, in particular, the private sector’s role in their provision. This investment trust was launched in 1995 and its portfolio manager is Orbimed Advisors, a privately owned New York-based group. With a market value